Face mask use and control of respiratory virus transmission in households

Emerging Infectious Diseases

Volumn 15, Issue 2, 2009, Pages 233-241

  Maclntyre, C Raina ^a,b   Cauchemez, Simon ^c   Dwyer, Dominic E ^d   Seale, Holly ^a   Cheung, Pamela ^b   Browne, Gary ^b   Fasher, Michael ^e   Wood, James ^a   Gao, Zhanhai ^a   Booy, Robert ^b   Ferguson, Neil ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d WESTMEAD HOSPITAL   (Australia)

^e Wentworth Division of General Practice   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONAVIRUS; DISEASE ASSOCIATION; DISEASE CONTROL; ENTEROVIRUS; EXPOSURE; FACE MASK; HOUSEHOLD; HUMAN; HUMAN METAPNEUMOVIRUS; INFANT; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; PANDEMIC; PARAINFLUENZA VIRUS; PATIENT COMPLIANCE; PICORNAVIRUS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; RHINOVIRUS; RISK REDUCTION; SCHOOL CHILD; SURGICAL MASK; VIRUS TRANSMISSION; WINTER;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MASKS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SEASONS; TREATMENT OUTCOME;

EID: 63849263089     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1502.081167     Document Type: Article

References (32)

1. Cauchemez S, Valleron A-J, Boelle P-Y, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from sentinel data. Nature. 2008;452:750-4. DOI: 10.1038/na- ture06732
2. Rabie T, Curtis V. Handwashing and risk of respiratory infections: a quantitative systematic review. Trop Med Int Health. 2006;11:258- 67. DOI: 10.1111/j.1365-3156.2006.01568.x
3. Larson E, Aiello A, Lee LV, Della-Latta P, Gomez-Duarte C, Lin S. Short- and long-term effects of handwashing with antimicrobial or plain soap in the community. J Community Health. 2003;28:139-50. DOI: 10.1023/A:1022699514610
4. Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann Intern Med. 2004;140:321-9.
5. Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, et al. Effect of handwashing on child health: a randomized controlled trial. Lancet. 2005;366:225-33. DOI: 10.1016/S0140-6736- (05)66912-7
6. Luby SP, Agboatwalla M, Painter J, Altaf A, Billhimer WL, Hoekstra RM. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. JAMA. 2004;291:2547-54. DOI: 10.1001/jama.291.21.2547
7. Black RE, Dykes AC, Anderson KE, Wells JG, Sinclair SP, Gary GW Jr, et al. Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol. 1981;113:445-51.
8. Girou E, Loyeau S, Legrand P, Oppein F, Brun-Buisson C. Efficacy of handrubbing with alcohol-based solution versus standard handwashing with antiseptic soap: randomized clinical trial. BMJ. 2002;325:362. DOI: 10.1136/bmj.325.7360.362
9. Le CT. Statistical comparison of two handwashing protocols. Stat Med. 1986;5:393-6. DOI: 10.1002/sim.4780050412
10. Pereira LJ, Lee GM, Wade KJ. An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts. J Hosp Infect. 1997;36:49-65. DOI: 10.1016/S0195-6701-(97)90090-6
11. Slota M, Green M, Farley A, Janosky J, Carcillo J. The role of gown and glove isolation and strict handwashing in the reduction of noso- comial infection in children with solid organ transplantation. Crit Care Med. 2001;29:405-12. DOI: 10.1097/00003246-200102000-00034
12. Cowling BJ, Fung ROP, Cheng CKY, Fang VJ, Chan KH, Seto WH, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One. 2008;3:e2101. DOI: 10.1371/journal.pone.0002101
13. Kao T-W, Huang K-C, Huang Y-L, Tsai T-J, Hsieh B-S, Wu M-S. The physiological impact of wearing an N95 mask during hemodi- alysis as a precaution against SARS in patients with end-stage renal disease. J Formos Med Assoc. 2004;103:624-8.
14. Lim ECH, Seet RCS, Lee KH, Wilder-Smith EPV, Chuah BYS, Ong BKC. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand. 2006;113:199-202. DOI: 10.1111/j.1600-0404.2005.00560.x
15. Mardimae A, Slessarev M, Han J, Sasano H, Sasano N, Azami T, et al. Modified N95 mask delivers high inspired oxygen concentrations while effectively filtering aerosolized microparticles. Ann Emerg Med. 2006;48:391-9. DOI: 10.1016/j.annemergmed.2006.06.039
16. Department of Health and Human Services. HHS pandemic influenza plan. Washington: The Department; 2005.
17. Australian health management plan for pandemic influenza: important information for all Australians. Canberra: Department of Health and Ageing, Commonwealth of Australia; 2006.
18. National plan for the prevention and control of influenza pandemic. Paris: General Secretariat for National Defence; 2007.
19. 3M technical update: P2 respirators vs. N95 respirators. 3M Australia; 2005 [cited 2008 Dec 29]. Available from http://multimedia.mmm.com/mws/ mediawebserver. dyn?6666660Zjcf6IVs66S4wScO rrrrQ
20. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomized trials. BMJ. 2004;328:702-8. DOI: 10.1136/bmj.328.7441.702
21. Druce J, Tran T, Kelly H, Kaye M, Chibo D, Kostecki R, et al. Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol. 2005;75:122-9. DOI: 10.1002/jmv.20246
22. Carrat F, Sahler C, Rogez S, Leruez-Ville M, Freymuth F, Le Gales C, et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med. 2002;162:1842-8. DOI: 10.1001/archinte.162.16.1842
23. Viboud C, Boelle P-Y, Cauchemez S, Lavenu A, Valleron A-J, Fla- hault A, et al. Risk factors of influenza transmission in households. Br J Gen Pract. 2004;54:684-9.
24. Therneau TM, Grambsch P. Statistics for biology and health: modelling survival data-extending the Cox model. New York: Springer; 2006.
25. Seto WH, Tsang D, Yung RWH, Ching TY, Ng TK, Ho M, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361:1519-20. DOI: 10.1016/S0140-6736- (03)13168-6
26. Harris JM II, Gwaltney JM Jr. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis. 1996;23:1287-90.
27. Cava MA, Fay KE, Beanlands HJ, McCay EA, Wignall R. Risk perception and compliance with quarantine during the SARS outbreak. J Nurs Scholarsh. 2005;37:343-7. DOI: 10.1111/j.1547-5069.2005.00059.x
28. Lo JYC, Tsang THF, Leung Y-H, Yeung EYH, Wu T, Lim WWL. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis. 2005;11:1738-41.
29. Syed Q, Sopwith W, Regan M, Bellis MA. Behind the mask. Journey through an epidemic: some observations of contrasting public health responses to SARS. J Epi Comm Health. 2003 November 1, 2003;57:855-6.
30. Macintyre CR, Goebel K, Brown GV. Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels. Prev Med. 2005;40:41-5. DOI: 10.1016/j.ypmed.2004.04.045
31. Booy R, Brown LE, Grohmann GS, Macintyre CR. Pandemic vaccines: promises and pitfalls. Medical Journal of Australia. 2006;185(Suppl):S62-5.
32. World Health Organization. Influenza A (H1N1) virus resistance to oseltamivir-last quarter 2007 to 2 June 2008. [cited 2008 Aug 29]. Available from http://www.who.int/csr/disease/influenza/oseltami-vir-summary/en/index.html